| Invested through |
|
|---|---|
| Asset Classes | Listed equity |
| Impact strategy | Impact Equities and Bonds |
| Bloomberg ticker | BBG000BLL8K7 |
| ISIN code | DK0060336014 |
| Industry group | Materials |
| Aligned with SDGs |
Novonesis was formed following the completion of the merger between Novozymes and Chr. Hansen in January 2024. The merger created a world leader in biosolutions, combining Novozymes' market-leading position in enzymes with Chr. Hansen's market-leading position in cultures and probiotics. The business operates under four segments in two divisions: Food & Beverages and Human Health in the Food & Health Biosolutions division, and Household Care and Agriculture, Energy & Tech in the Planetary Health Biosolutions division. The company has more than 10,000 employees worldwide.
Investment rationale
Novonesis supports sustainable transitions in food, health, household care, energy and agriculture, contributing to three of our transitions: Food, Wellbeing and Energy.
Food transition: The company's products improve food taste, texture, yield, and shelf life while reducing sugar, fat, and salt. Its bio-solutions help prevent food waste (e.g., saving 1M tons of yogurt in 9 years) and enhance agricultural yields, crop resilience, and animal health while reducing antibiotic use.
Wellbeing transition: The company promotes gut, immune, and healthy ageing solutions through probiotics and other bio-products. In household care, it enables low-temperature washing, reduces chemical use (saving 170,000 tons of detergents in Europe in 2024), lowers transport emissions, and lessens ecological toxicity by reducing petroleum-based surfactants.
Energy transition: The company supports sustainable agriculture, improves ethanol production efficiency, and facilitates low-carbon fuels, helping avoid over 60 million tons of CO₂e emissions annually in transport.
45% of revenues is aligned with the Food Transition, 31% with the Wellbeing Transition and 18% with the Energy transition.